Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

0.8600 -0.0200 (-2.27%)
Streaming Delayed Price Updated: 9:36 AM EDT, Apr 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 111,385
Open 0.9050
Bid (Size) 0.8500 (4,200)
Ask (Size) 0.8700 (13,400)
Prev. Close 0.8800
Today's Range 0.8012 - 0.9050
52wk Range 0.4600 - 1.550
Shares Outstanding 24,887,446
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
Via ACCESS Newswire
News headline image
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
Via ACCESS Newswire

Performance

YTD
+31.5%
+31.5%
1 Month
+10.3%
+10.3%
3 Month
+10.6%
+10.6%
6 Month
-9.7%
-9.7%
1 Year
-29.5%
-29.5%

More News

Read More
News headline image
Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales
Via ACCESS Newswire
News headline image
Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property
Via ACCESS Newswire
News headline image
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
Via ACCESS Newswire
News headline image
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
Via TheNewswire.com
News headline image
Lexaria to Begin New Human Clinical Study in GLP-1
Via ACCESS Newswire
News headline image
Lexaria's Robust Patent Portfolio Continues to Grow
Via ACCESS Newswire
News headline image
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
Via ACCESS Newswire
News headline image
Lexaria Announces New R&D Plans for 2026
Via ACCESS Newswire
News headline image
Lexaria Announces Positive Final Results From Human Pilot Study #5
Via ACCESS Newswire
News headline image
Lexaria Awarded Six Additional Patents
Via TheNewswire.com
Topics Intellectual Property
News headline image
Lexaria Awarded Six Additional Patents
Via ACCESS Newswire
News headline image
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
From USA News Group
Via GlobeNewswire
News headline image
Lexaria Releases Annual Letter from the CEO
Via ACCESS Newswire
News headline image
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
Via ACCESS Newswire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
News headline image
Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4
Via ACCESS Newswire
News headline image
Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Which stocks are gapping on Monday? ↗
Via Chartmill
News headline image
Monday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
News headline image
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended
Via ACCESS Newswire

Frequently Asked Questions

Is Lexaria Bioscience Corp. - Common Stock publicly traded?
Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Common Stock?
The current price of Lexaria Bioscience Corp. - Common Stock is 0.8600
When was Lexaria Bioscience Corp. - Common Stock last traded?
The last trade of Lexaria Bioscience Corp. - Common Stock was at 04/29/26 09:36 AM ET
What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?
The market capitalization of Lexaria Bioscience Corp. - Common Stock is 21.40M
How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?
Lexaria Bioscience Corp. - Common Stock has 21M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.